All Sites Sorted » Health Beauty and Fitness » Medicine




Latest News

Rich Pharmaceuticals Appoints Professor Richard L. Chang to Medical Advisory Board
BEVERLY HILLS, Calif. -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") is pleased to announce the appointment of Professor Richard L. Chang to the Company's Medical ... Thu, 17 Apr 2014 06:00:00 -0700

Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality
MOUNTAIN VIEW, Calif., April 17, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (ALXA) announced today that Winston R. Brown, Jr. has joined the Company as Vice President, Quality.  Mr. Brown brings more than two decades of experience in global quality, regulatory compliance and development operations working with diverse biopharmaceuticals, medical devices and nutritionals in globally ... Thu, 17 Apr 2014 06:00:00 -0700

Pacira Pharmaceuticals Announces Timing for First Quarter 2014 Financial Results Webcast and Conference Call
Pacira Pharmaceuticals, Inc. today announced that financial results for the company’s first quarter ended March 31, 2014, will be released before the market opens on Thursday, May 1, 2014. Thu, 17 Apr 2014 03:30:00 -0700

AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role ...
WALTHAM, Mass. -- AMAG Pharmaceuticals, Inc. today announced new appointments to its board of directors. Current board member, Gino Santini, has been elected, by unanimous vote, to chairman of the board ... Wed, 16 Apr 2014 14:00:00 -0700

Dicerna Pharmaceuticals Initiates Phase 1 Study of DCR-MYC in Patients with Solid Tumors and Hematological Malignancies
Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, today announced the initiation of a Phase 1 dose-escalating clinical study of DCR-MYC, , in patients with solid tumors, multiple myeloma, or lymphoma. Wed, 16 Apr 2014 13:15:00 -0700

Kolltan Pharmaceuticals Expands Company's Board of Directors
NEW HAVEN, Conn., April 16, 2014 /PRNewswire/ -- Kolltan Pharmaceuticals, a privately held biopharmaceutical company focused on the development of novel biologics targeting receptor tyrosine kinases, today announced the election of Dr. Daniel R. Vlock to the Company's Board of Directors.  In addition, William S. Slattery will join the Board of Directors as an observer representing Deerfield ... Wed, 16 Apr 2014 05:00:00 -0700

Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven diseases, today announced the appointment of Karen J. Tue, 15 Apr 2014 05:30:00 -0700

Synta Pharmaceuticals Enters Into Agreement to Sell $5.0 Million in Common Stock Directly to an Affiliate of Synta ...
Synta Pharmaceuticals Corp. today announced the entry into a Subscription Agreement with an entity affiliated with Bruce Kovner, one of Synta’s directors and its largest stockholder, to sell 1,250,000 shares of its common stock at a price of $4.01 per share. Mon, 14 Apr 2014 05:00:00 -0700

Easton Pharmaceuticals Signs "Viorra" Distribution Deal for Mexico
Easton Pharmaceuticals is pleased to announce that BMV Medica, S.A. de C.V., a Mexican regulatory company and distributor of pharmaceutical products have signed an exclusive agreement to distribute Easton's ... Mon, 14 Apr 2014 05:00:00 -0700

Rich Pharmaceuticals Warns Investors of Unauthorized Spam Stock Promotion
BEVERLY HILLS, Calif. -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company"), has been made aware of a recent spam stock promotion regarding shares of Rich. Rich has received ... Mon, 14 Apr 2014 04:00:00 -0700

Website Directory Sort by: Hits | Alphabetical


Top 5 Web Hosts

Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost